DEF 14C: Quantumzyme Rebrands to Quantum Genesis AI Corp.

Quantumzyme Corp. announces a corporate name change to Quantum Genesis AI Corp., signaling a strategic focus on artificial intelligence.

Summary

• Quantumzyme Corp. is changing its corporate name to Quantum Genesis AI Corp.
• The name change was approved by the Company's Board of Directors and by written consent of stockholders holding 31,000,000 shares, representing approximately 79.565% of the outstanding voting power, on November 30, 2025.
• The change will become effective at least twenty (20) calendar days after the Information Statement is mailed or furnished to stockholders, which is on or about January 20, 2026.
• No meeting of stockholders was held as the requisite majority approval was obtained via written consent.
• The name change will not affect stockholder rights, authorized capital, issued and outstanding shares, CUSIP number, or par value.
• No dissenters' rights of appraisal are available to stockholders in connection with this action.

Sentiment

Score: 7

Explanation: The name change to include 'AI' is generally perceived positively in the current market, suggesting a strategic pivot or emphasis on a high-growth sector, which could attract investor interest. However, the filing itself is purely procedural and lacks operational or financial details.

Positives

• The rebranding to 'Quantum Genesis AI Corp.' may enhance market perception and investor interest by aligning the company with the high-growth artificial intelligence sector.
• The approval process via written consent avoided the costs and management time associated with holding a special meeting of stockholders.

Future Outlook

The name change to Quantum Genesis AI Corp. suggests a future strategic emphasis or pivot towards artificial intelligence, aiming to reflect a new direction or focus for the company.

Management Comments

• "The enclosed Information Statement is being furnished to the holders of shares of common stock... in connection with actions approved by the Company's Board of Directors and by the written consent of stockholders holding a majority of the Company's outstanding voting power to amend the Company's Articles of Incorporation to change the Company's name to Quantum Genesis AI Corp."

Industry Context

The company's decision to incorporate 'AI' into its name aligns with a broader industry trend where companies are rebranding or emphasizing their involvement in artificial intelligence to capitalize on investor enthusiasm and reflect technological advancements. This move positions the company within a highly scrutinized and rapidly evolving sector.

Corporate Governance

Stakeholder Impact

• Shareholders: No direct impact on rights, authorized capital, or share value. Potential indirect impact through market perception of the new AI focus, which could influence stock valuation.
• Customers/Suppliers: Potential shift in brand identity and perceived business focus, which may influence future relationships.

Next Steps

• The Company will file a Certificate of Amendment with the Nevada Secretary of State to effect the Name Change after the mandatory twenty (20) calendar day waiting period following the mailing of the Information Statement.

Key Dates

Recommendation

While the name change to include 'AI' could generate short-term speculative interest due to current market trends, the filing provides no substantive details on the company's actual business operations, financial performance, or strategic execution within the AI sector. Investors should hold and await further operational updates and financial disclosures to assess the true impact and viability of this strategic pivot.

Keywords

Quantumzyme Corp., Quantum Genesis AI Corp., Name Change, Corporate Rebranding, Artificial Intelligence, AI, SEC Filing, DEF 14C, Corporate Governance, Stockholder Approval